Health Cor Management, L.P. Aerie Pharmaceuticals Inc Transaction History

Health Cor Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $3.58 Million - $7.71 Million	-302,290 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $17.9 Million - $25.4 Million	-1,012,000 Reduced 77.0%	302,290 $7.31 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $9.31 Million - $16.9 Million	282,163 Added 27.34%	1,314,290 $88.8 Million
Q3 2018 Nov 15, 2018	SELL	$56.15 - $73.9 $15.8 Million - $20.9 Million	-282,163 Reduced 21.47%	1,032,127 $63.5 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $5.47 Million - $8.05 Million	114,290 Added 9.52%	1,314,290 $88.8 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $61.4 Million - $73.2 Million	1,200,000 New	1,200,000 $65.1 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.